Target Tetra® Detachable Coil study results
A big deal for small spaces
This study retrospectively reviewed the medical records of 41 patients with 46 aneurysms (45 unruptured and 1 ruptured), who underwent the coil embolization of intracranial aneurysms sized ≤10mm with Target Tetra Detachable Coils between April and May 2023. Post-procedural angiographic and clinical results were reviewed.
Primary endpoints:
Immediate aneurysm complete occlusion rate (Raymond scale)
Secondary endpoints:
Angiographic complete occlusion rate at first follow-up (Raymond scale), recanalization and retreatment rates, and device or procedure-related complications
Results are in
Discover the Target Tetra Detachable Coil
Target Tetra Detachable Coil
See package insert for complete indications, contraindications, warnings and instructions for use.
RX ONLY
Indications for use
Target Detachable Coils are intended to endovascularly obstruct or occlude blood flow in vascular abnormalities of the neurovascular and peripheral vessels.
Target Detachable Coils are indicated for endovascular embolization of:
Contraindications
None known.
Potential adverse events
Potential complications include, but are not limited to: allergic reaction, aneurysm perforation and rupture, arrhythmia, death, embolus, headache, hemorrhage, infection, ischemia, neurological/intracranial sequelae, transient ischemic attack (TIA)/stroke, vasospasm, vessel occlusion or closure, vessel perforation and rupture, vessel dissection, vessel thrombosis, other procedural complications including but not limited to: anesthetic and contrast media risks, hypertension and hypotension, access site complications.
Any serious product-related incidents should be reported to both Stryker Neurovascular and a competent authority or equivalent regulatory authority, where the user and/or patient is established. Please make every attempt to retain any suspect device, its associated components and their packaging for return to Stryker Neurovascular.
Warnings
Cautions / precautions
Kim, W.; Jee, T.K.; Yeon, J.Y.; Kim, K.H.; Kim, J.-S.; Jeon, P. Endovascular Embolization of Intracranial Aneurysms Using Target Tetra Detachable Coils: Angiographicand Clinical Results from a Single Center. J. Clin. Med. 2024, 13, 4940. https://doi.org/10.3390/jcm13164940
A physician must always rely on his or her own professional clinical judgment when deciding whether to use a particular product when treating a particular patient. Stryker does not dispense medical advice and recommends that physicians be trained in the use of any particular product before using it in a procedure. The information presented is intended to demonstrate the breadth of Stryker product offerings. A physician must always refer to the package insert, product label and/or instructions for use before using any Stryker product. Products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in individual markets. Please contact your Stryker representative if you have questions about the availability of Stryker products in your area.
Stryker Corporation or its divisions or other corporate affiliated entities own, use, or have applied for the following trademarks or service marks: Stryker, Target, Target Tetra. All other trademarks are trademarks of their respective owners or holders.
The absence of a product, feature, or service name, or logo from this list does not constitute a waiver of Stryker’s trademark or other intellectual property rights concerning that name or logo.
AP004712 v1.0